Clinical Trial Update: Preoperative Downstaging of Extraperitoneal T3 Rectal Cancer: XELOXRT Versus XELACRT. A Multicenter, Phase III Study [Phase 3]

View source ↗

Summary

A multicenter Phase III trial comparing XELOXRT versus XELACRT for preoperative downstaging of extraperitoneal T3 rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• XELACRT
• XELOXRT

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Rectal Cancer | Phase 3 | Status: UNKNOWN